Allogeneic CD19-CAR-NK cells

CD19-CAR-NK cells · Guangdong ProCapZoom Biosciences Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic CD19-CAR-NK cells, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis [EARLY_Phase 1]